INDIANAPOLIS and WEST LAFAYETTE, Ind. - Eli Lilly and Company (NYSE: LLY), a pharmaceutical giant with annual revenue exceeding $49 billion and an impressive 81.7% gross profit margin, and Purdue ...

Tokyo, Japan and Cambridge, UK, 2 June 2025 – Nxera Pharma Co., Ltd. (“Nxera ... target collaboration and license agreement with Eli Lilly and Company (“Lilly”) targeting diabetes ...

Eli Lilly and Co. and Purdue University announced today a significant expansion of their long-standing alliance ... innovation at every stage of the pharmaceutical pipeline.

Eli Lilly is expanding its pain drug ... collaborator and investor in the startup, though an alliance on NaV1.7 drugs ended when the pharma giant exited neuroscience R&D. Late last year, Novo ...

May 9, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Purdue University announced today a significant expansion of their long-standing alliance ... stage of the pharmaceutical pipeline.

Eli Lilly is investing ... the Lilly and Purdue Research Alliance Center, according to the release. The long-time partners also announced the new Young Institute Pharmaceutical Manufacturing ...

INDIANAPOLIS and WEST LAFAYETTE, May 9, 2025 — Eli Lilly and Company (NYSE: LLY) and Purdue University announced Friday (May 9) a significant expansion of their long-standing alliance ... at every ...

May 9, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Purdue University announced today a significant expansion of their long-standing alliance ... stage of the pharmaceutical pipeline.

Eli Lilly and Company and Purdue University announced a significant expansion of their long-standing alliance, with Lilly's planned ... will seek to accelerate innovation at every stage of the ...

Sidekick is also working with a number of other pharma companies on companion ... and other chronic conditions. The new Lilly alliance is one of three that Sidekick expects to announce in the ...